Cargando…
Humoral Response to Hepatitis B and COVID-19 Vaccine among Maintenance Hemodialysis Patients
Maintenance hemodialysis (MHD) patients have impaired immunological responses to pathogens and vaccines. In this study, we compared the humoral response to HBV and COVID-19 vaccines in a cohort of MHD patients. Demographic and clinical characteristics of vaccine responders and non-responders were al...
Autores principales: | Nacasch, Naomi, Cohen-Hagai, Keren, Tayar, Nurit, Levian, Avraham, Rashid, Gloria, Benchetrit, Sydney, Neumark, Eran, Wand, Ori, Hod, Tammy, Rosman, Yossi, Shashar, Moshe, Grupper, Ayelet, Shitrit, Pnina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610516/ https://www.ncbi.nlm.nih.gov/pubmed/36298535 http://dx.doi.org/10.3390/vaccines10101670 |
Ejemplares similares
-
Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients
por: Wand, Ori, et al.
Publicado: (2022) -
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022) -
Kinetics of the humoral response 1-year following vaccination with BNT162b2 SARS-CoV-2 vaccine among maintenance hemodialysis patients
por: Wand, Ori, et al.
Publicado: (2022) -
Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients
por: Einbinder, Yael, et al.
Publicado: (2022) -
Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients
por: Nacasch, Naomi, et al.
Publicado: (2022)